EMBLA — Embla Medical hf Balance Sheet
0.000.00%
- DKK12.83bn
- DKK15.64bn
- $928.69m
- 72
- 33
- 56
- 54
Annual balance sheet for Embla Medical hf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 85.2 | 76.6 | 72.7 | 87.6 | 103 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 107 | 117 | 133 | 129 | 154 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 318 | 349 | 376 | 397 | 458 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 182 | 179 | 186 | 200 | 243 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,247 | 1,325 | 1,386 | 1,539 | 1,730 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 186 | 237 | 196 | 209 | 310 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 625 | 690 | 684 | 762 | 840 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 622 | 636 | 702 | 777 | 891 |
| Total Liabilities & Shareholders' Equity | 1,247 | 1,325 | 1,386 | 1,539 | 1,730 |
| Total Common Shares Outstanding |